The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
β-Peptidic Peptidomimetics
Abstract
For more than a decade now, a search for answers to the following two questions has taken us on a new and exciting journey into the world of beta- and gamma-peptides: What happens if the oxygen atoms in a 3i-helix of a polymeric chain composed of (R)-3-hydroxybutanoic acid are replaced by NH units? What happens if one or two CH2 groups are introduced into each amino acid building block in the chain of a peptide or protein, thereby providing homologues of the proteinogenic alpha-amino acids? Our journey has repeatedly thrown up surprises, continually expanding the potential of these classes of compound and deepening our understanding of the structures, properties, and multifaceted functions of the natural "models" to which they are related. Beta-peptides differ from their natural counterparts, the alpha-peptides, by having CH2 groups inserted into every amino acid residue, either between the C=O groups and the alpha-carbon atoms (beta(3)) or between the alpha-carbon and nitrogen atoms (beta(2)). The synthesis of these homologated proteinogenic amino acids and their assembly into beta-peptides can be performed using known methods. Despite the increased number of possible conformers, the beta-peptides form secondary structures (helices, turns, sheets) even when the chain lengths are as short as four residues. Furthermore, they are stable toward degrading and metabolizing enzymes in living organisms. Linear, helical, and hairpin-type structures of beta-peptides can now be designed in such a way that they resemble the characteristic and activity-related structural features ("epitopes") of corresponding natural peptides or protein sections. This Account presents examples of beta-peptidic compounds binding, as agonists or antagonists (inhibitors), to (i) major histocompatibility complex (MHC) proteins (immune response), (ii) the lipid-transport protein SR-B1 (cholesterol uptake from the small intestine), (iii) the core (1-60) of interleukin-8 (inflammation), (iv) the oncoprotein RDM2, (v) the HIVgp41 fusion protein, (vi) G-protein-coupled somatostatin hsst receptors, (vii) the TNF immune response receptor CD40 (apoptosis), and (viii) DNA. Short-chain beta-peptides may be orally bioavailable and excreted from the body of mammals; long-chain beta-peptides may require intravenous administration but will have longer half-lives of clearance. It has been said that an interesting field of research distinguishes itself in that the results always throw up new questions; in this sense, the structural and biological investigation of beta-peptides has been a gold mine. We expect that these peptidic peptidomimetics will play an increasing role in biomedical research and drug development in the near future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
β-Peptides: From Structure to Function
Cheng, R. P., Gellman, S. H., & DeGrado, W. F. (2001) · Chemical Reviews · doi:10.1021/cr000045i · Cited by 1,862
van Kooten, C., & Banchereau, J. (2000) · Journal of Leukocyte Biology · doi:10.1002/jlb.67.1.2 · Cited by 1,404
Seebach, D., Beck, A. K., & Bierbaum, D. J. (2004) · Chemistry & Biodiversity · doi:10.1002/cbdv.200490087 · Cited by 932
Self-citationSeebach, D., Overhand, M., Kühnle, F. N. M., Martinoni, B., Oberer, L., Hommel, U., & Widmer, H. (1996) · Helvetica Chimica Acta · doi:10.1002/hlca.19960790402 · Cited by 734
Self-citationβ-Peptide Foldamers: Robust Helix Formation in a New Family of β-Amino Acid Oligomers
Appella, D. H., Christianson, L. A., Karle, I. L., Powell, D. R., & Gellman, S. H. (1996) · Journal of the American Chemical Society · doi:10.1021/ja963290l · Cited by 705
Human antibodies from transgenic animals.
Lonberg, N. (2005) · Nature Biotechnology · doi:10.1038/nbt1135 · Cited by 434
GENERATION, TRANSLOCATION, AND PRESENTATION OF MHC CLASS I-RESTRICTED PEPTIDES
Heemels, M.-T., & Ploegh, H. (1995) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.64.070195.002335 · Cited by 428
Therapeutic antibody fragments with prolonged in vivo half-lives
Chapman, A. P., Antoniw, P., Spitali, M., West, S., Stephens, S., & King, D. J. (1999) · Nature Biotechnology · doi:10.1038/11717 · Cited by 350
β2‐amino acids—syntheses, occurrence in natural products, and components of β‐peptides1,2
Lelais, G., & Seebach, D. (2004) · Peptide Science · doi:10.1002/bip.20088 · Cited by 322
Self-citationHelical β-Peptide Inhibitors of the p53-hDM2 Interaction
Kritzer, J. A., Lear, J. D., Hodsdon, M. E., & Schepartz, A. (2004) · Journal of the American Chemical Society · doi:10.1021/ja031625a · Cited by 314
Seebach, D., Abele, S., Gademann, K., Guichard, G., Hintermann, T., Jaun, B., Matthews, J. L., Schreiber, J. V., Oberer, L., Hommel, U., et al. (1998) · Helvetica Chimica Acta · doi:10.1002/hlca.19980810513 · Cited by 302
Self-citationTranslocation of a β-Peptide Across Cell Membranes
Umezawa, N., Gelman, M. A., Haigis, M. C., Raines, R. T., & Gellman, S. H. (2002) · Journal of the American Chemical Society · doi:10.1021/ja017283v · Cited by 226
Over One Hundred Peptide-Activated G Protein-Coupled Receptors Recognize Ligands with Turn Structure
Tyndall, J. D. A., Pfeiffer, B., Abbenante, G., & Fairlie, D. P. (2005) · Chemical Reviews · doi:10.1021/cr040689g · Cited by 222
β-Peptides as Inhibitors of Small-Intestinal Cholesterol and Fat Absorption
Werder, M., Hauser, H., Abele, S., & Seebach, D. (1999) · Helvetica Chimica Acta · doi:10.1002/(sici)1522-2675(19991006)82:10<1774::aid-hlca1774>3.0.co;2-o · Cited by 209
Self-citationDaura, X., Gademann, K., Schäfer, H., Jaun, B., Seebach, D., & van Gunsteren, W. F. (2001) · Journal of the American Chemical Society · doi:10.1021/ja003689g · Cited by 201
Self-citationSynthesis and Biological Evaluation of a Cyclo--tetrapeptide as a Somatostatin Analogue
Gademann, K., Ernst, M., Hoyer, D., & Seebach, D. (1999) · Angewandte Chemie International Edition · doi:10.1002/(sici)1521-3773(19990503)38:9<1223::aid-anie1223>3.0.co;2-a · Cited by 200
Self-citationβ-Peptides as inhibitors of protein–protein interactions
Kritzer, J. A., Stephens, O. M., Guarracino, D. A., Reznik, S. K., & Schepartz, A. (2005) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2004.09.009 · Cited by 182
Inhibiting HIV Fusion with a β-Peptide Foldamer
Stephens, O. M., Kim, S., Welch, B. D., Hodsdon, M. E., Kay, M. S., & Schepartz, A. (2005) · Journal of the American Chemical Society · doi:10.1021/ja053444+ · Cited by 174
How we drifted into peptide chemistry and where we have arrived at
Seebàch, D., Kimmerlin, T., Šebesta, R., Campo, M. A., & Beck, A. K. (2004) · Tetrahedron · doi:10.1016/j.tet.2004.06.043 · Cited by 117
Hitz, T., Iten, R., Gardiner, J., Namoto, K., Walde, P., & Seebàch, D. (2006) · Biochemistry · doi:10.1021/bi060285d · Cited by 74
Self-citationSolution Structure of a β-Peptide Ligand for hDM2
Kritzer, J. A., Hodsdon, M. E., & Schepartz, A. (2005) · Journal of the American Chemical Society · doi:10.1021/ja042933r · Cited by 73
C3-symmetric peptide scaffolds are functional mimetics of trimeric CD40L
Fournel, S., Wieckowski, S., Sun, W., Trouche, N., Dumortier, H., Bianco, A., Chaloin, O., Habib, M., Peter, J., Schneider, P., et al. (2005) · Nature Chemical Biology · doi:10.1038/nchembio746 · Cited by 72
Selective Binding of TAR RNA by a Tat-Derived β-Peptide
Gelman, M. A., Richter, S. N., Cao, H., Umezawa, N., Gellman, S. H., & Rana, T. M. (2003) · Organic Letters · doi:10.1021/ol034977v · Cited by 70
Arvidsson, P. I., Ryder, N. S., Weiss, H., Hook, D. F., Escalante, J., & Seebàch, D. (2005) · Chemistry & Biodiversity · doi:10.1002/cbdv.200590020 · Cited by 64
Permeation of a β-heptapeptide derivative across phospholipid bilayers
Shimanouchi, T., Walde, P., Gardiner, J., et al. (2007) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.07.011 · Cited by 46
Self-citationLelais, G., Seebàch, D., Jaun, B., Mathad, R. I., Flögel, O., Rossi, F., Campo, M. A., & Wortmann, A. (2006) · Helvetica Chimica Acta · doi:10.1002/hlca.200690040 · Cited by 40
Trouche, N., Wieckowski, S., Sun, W., et al. (2007) · Journal of the American Chemical Society · doi:10.1021/ja073169m · Cited by 32
Poenaru, S., Lamas, J. R., Folkers, G., de Castro, J. A. Ł., Seebàch, D., & Rognan, D. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm981123l · Cited by 32
Oral amphipathic peptides as therapeutic agents
Reddy, S. T., Anantharamaiah, G. M., Navab, M., Hama, S. Y., Hough, G. P., Grijalva, V. R., Garber, D. W., Datta, G., & Fogelman, A. M. (2005) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.15.1.13 · Cited by 23
Zinkernagel, R. M. (1997) · Angewandte Chemie International Edition in English · doi:10.1002/anie.199719381 · Cited by 7
Cited by
Yashima, E., Ousaka, N., Taura, D., Shimomura, K., Ikai, T., & Maeda, K. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00354 · Cited by 2,004
Small molecules, big targets: drug discovery faces the protein–protein interaction challenge
Scott, D. E., Bayly, A. R., Abell, C., & Skidmore, J. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.29 · Cited by 1,137
Peptidic foldamers: ramping up diversity
Martinek, T. A., & Fülöp, F. (2012) · Chem. Soc. Rev. · doi:10.1039/c1cs15097a · Cited by 485
Prebiotic Peptides: Molecular Hubs in the Origin of Life
Frenkel-Pinter, M., Samanta, M., Ashkenasy, G., & Leman, L. J. (2020) · Chemical Reviews · doi:10.1021/acs.chemrev.9b00664 · Cited by 354
Vasudev, P. G., Chatterjee, S., Shamala, N., & Balaram, P. (2011) · Chemical Reviews · doi:10.1021/cr100100x · Cited by 329
Metadata
- Authors
- Seebach, D., & Gardiner, J.
- Venue
- Accounts of Chemical Research
- Publisher
- American Chemical Society (ACS)
- Published
- 2008-06-26
- Volume
- 41
- Issue
- 10
- Pages
- 1366-1375
- ISSN
- 0001-4842 (ISSN-L)
- 1520-4898
- OpenAlex
- W2086167852
- Cited by
- 709
- References
- 30
- FWCI
- 18.12
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.